Overexpression of B cell activating factor of TNF family (BAFF) is associated with Helicobacter pylori independent growth of gastric diffuse large B-cell lymphoma with histologic evidence of MALT lymphoma

Blood

Volumn 112, Issue 7, 2008, Pages 2927-2934

  Kuo, Sung Hsin ^a   Yeh, Pei Yen ^a,b   Chen, Li Tzong ^c,e   Wu, Ming Shiang ^a   Lin, Chung Wu ^a   Yeh, Kun Huei ^a,b   Tzeng, Yi Shin ^a,b   Chen, Jing Yi ^a,b   Hsu, Ping Ning ^a   Lin, Jaw Town ^a   Cheng, Ann Lii ^a,b,d  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; B CELL ACTIVATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL 10; PROTEIN KINASE B; BCL10 PROTEIN, HUMAN; ONCOPROTEIN; PROTO ONCOGENE PROTEIN BCL 3; PROTO-ONCOGENE PROTEIN BCL-3; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TRANSCRIPTION FACTOR;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BACTERIAL GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; ENZYME ACTIVATION; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE OVEREXPRESSION; GENE TRANSLOCATION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STOMACH LYMPHOMA; UPREGULATION; BIOLOGICAL MODEL; CELL NUCLEUS; ENZYMOLOGY; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROTEIN TRANSPORT; STOMACH TUMOR; TUMOR CELL LINE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; AGED, 80 AND OVER; B-CELL ACTIVATING FACTOR; CELL LINE, TUMOR; CELL NUCLEUS; ENZYME ACTIVATION; FEMALE; HELICOBACTER PYLORI; HUMANS; LYMPHOMA, B-CELL, MARGINAL ZONE; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; NF-KAPPA B; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 53449098647     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-02-137513     Document Type: Article

References (46)

1. Chen LT, Lin JT, Tai JJ, et al. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma. J Natl Cancer Inst. 2005;97:1345-1353.
2. Kuo SH. Chen LT, Yeh KH, et al. Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of earlystage, high-grade gastric mucosa-associated lymphoid tissue lymphomas. J Clin Oncol. 2004; 22:3491-3497.
3. Yeh KH, Kuo SH, Chen LT, et al. Nuclear expression of BCL10 or nuclear factor kappa B helps predict Helicobacter pylori-independent status of low-grade gastric mucosa-associated lymphoid tissue lymphomas with or without t(11;18)(q21; q21). Blood. 2005;106:1037-1041.
4. Du MQ. MALT lymphoma: recent advances in aetiology and molecular genetics. J Clin Exp Heatop. 2007;47:31-42.
5. Willis TG, Jadayel DM, Du MQ, et al. Bcl10 is involved in t(1;14)(p22:q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell. 1999;96:35-45.
6. Wang D. You Y. Case SM, et al. A requirement for CARMA1 in TCR-induced NF-kappa B activation. Nat Immunol. 2002;3:830-835.
7. Ruland J, Duncan GS, Elia A. Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kappaB and neural tube closure. Cell. 2001;104:33-42.
8. Xue L, Morris SW, Orihuela C, et al. Defective development and function of BCL10-deficient follicular, marginal zone and B1 B cells. Nat Immunol. 2003;4:857-865.
9. Karin M, CaoY, Greten FR, et al. NF-kappaB in cancer: from innocent bystander to major culprit. Nat Rev Cancer. 2002;2:301-310.
10. Yeh PH, Kuo SH, Yeh KH, et al. A pathway for TNFα-induced Bcl10 nuclear translocation: Bcl1O is up-regulated by NF-κB, phosphorylated by Akt1 and then complexes with Bcl3 to enter nucleus. J Biol Chem. 2006;281:167-175.
11. Moore PA, Belvedere O, OrrA, et al. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science. 1999;285:260-263.
12. Schneider P, MacKay F, Steiner V, et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med. 1999;189: 1747-1756.
13. Batten M, Fletcher C, Ng LG, et al. TNFdeficiency fails to protect BAFF transgenic mice against autoimrnunity and reveals a prediction to B cell lymphoma. J Immunol. 2004;172:812-822.
14. Novak AJ, Grote DM, Steven MS, et al. Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome. Blood. 2004;104: 2247-2253.
15. Fu L, Lin-Lee YC, Pham LV, et al. Constitutive NF-kappa B and N FAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas. Blood. 2006;107:4540-4548.
16. Kuo SH, Chen LT, Chen CL, et al. Expression of CD86 and increased infiltration of NK cells are associated with Helicobacter pylori-dependent state of early-stage high-grade gastric MALT lymphoma. World J Gastrosnterol. 2005;11:4357-4362.
17. Chan JK, Ng CS, Isaacson PG. Relationship between high-grade lymphoma and low-grade B-cell mucosa-associated lymphoid tissue lymphoma (MALToma) of the stomach. Am J Pathol. 1990;136:1153-1164.
18. de Jong D, Boot H, van Heerde P, et al. Histological grading in gastric lymphoma: pretreatment criteria and clinical relevance. Gastroenterology. 1997;112:1466-1474.
19. Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet. 1993; 342:575-577.
20. Mathas S, Johrens K, Joos S, et al. Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large-cell, and other peripheral T-cell lymphomas. Blood. 2005;106:4287-4293.
21. Schmitz KJ, Callies R, Wohlschlaeger J, et al. Overexpression of cyclo-oxygenase-2 is an independent predictor of unfavourable outcome in node-negative breast cancer, but is not associated with protein kinase B (Akt) and mitogenactivated protein kinase (ERK1/2, p38) activation or with Her-2/neu signalling pathways. J Clin Pathol. 2006;59:685-691.
22. Kasprzak A, Zabel M, Biczysko W, et al. Expression of cytokines (TNF-alpha, IL-1alpha, and IL-2) in chronic hepatitis C: comparative hybridocytochemical and immunocytochemical study in children and adult patients. J Histochem Cytochem. 2004;52:29-38.
23. Elsawa SF, NovakAJ, Grote DM. et al. B-lymphocyte stimulator (BLyS) stimulates immunoglobulin production and malignant B-cell growth in Waldenstrom macroglobulinemia. Blood. 2006; 107:2882-2888.
24. NovakAJ, Bram RJ, Kay NE, Jelinek DF. Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: a mechanism for survival. Blood. 2002;100:2973-2979.
25. Vega F, Medeiros LJ, Leventaki V, et al. Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. Cancer Res. 2006;66:6589-6597.
26. Ye H, Dogan A, Karran L, et al. BCL10 expression in normal and neoplastic lymphoid tissue: nuclear localization in MALT lymphoma. Am J Pathol. 2000;157:1147-1154.
27. Ohshima K, Muta H, Kawasaki C, et al. BcI10 expression rearrangement and mutation in MALT lymphoma: correlation with expression of nuclear factor-kappa B. Int J Oncol. 2001;19:283-289.
28. David O, Jett J, LeBeau H, et al. Phospho-Akt overexpression in non-small cell lung cancer confers significant stage-independent survival disadvantage. Clin Cancer Res. 2004;10:6865-6871.
29. Gabay C, Ben-Bassat H, Schlesinger M, Laskov R. Somatic mutations and intraclonal variations in the rearranged Vkappa genes of B-non-Hodgkin's lymphoma cell lines. EurJ Haematol. 1999;63: 180-191.
30. Driessen A, Tierens A, Ectors N, et al. Primary diffuse large B cell lymphoma of the stomach: analysis of somatic mutations in the rearranged immunoglobulin heavy chain variable genes indicates antigen selection. Leukemia. 1999;13: 1085-1092.
31. Qin Y, Greiner A, Trunk MJ, et al. Somatic hypermutation in low-grade mucosa-associated lymphoid tissue-type B-cell lymphoma. Blood. 1995; 86:3528-3534.
32. Yeh PY, Chuang SE, Yeh KH, Song YC, Cheng AL. Nuclear extracellular signal-regulated kinase 2 phosphorylates p53 at Thr55 in response to doxorubicin. Biochem Biophy Res Comm. 2001; 284:880-886.
33. Wong CK, Cheung PF, Ip WK, Lam CW. Interleukin-25-induced chemokines and interleukin-6 release from eosinophils is mediated by p38 mitogen-activated protein kinase, c-Jun N-terminal kinase, and nuclear factor-kappaB. Am J Respir Cell Mol Biol. 2005;33:186-194.
34. Senftleben U, Cao Y, Xiao G, et al. Activation by IKKβ of a second, evolutionary conserved, NF-κB signaling pathway. Science. 2001;293:1495-1499.
35. Claudio E, Brown K, Park S, Wang H, Siebenlist U. BAFF-induced NEMO-independent processing of NF-κB2 in maturing B cells. Nat Immunol. 2002;3:958-965.
36. Kayagaki N, Yan M, Seshasayee D, et al. BAFF/BLyS receptor3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-κB2. Immunity. 2002; 17:515-524.
37. Kern C, Cornuel JF, Billard C, et al. Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLLthrough an autocrine pathway. Blood. 2004;103:679-688.
38. Moreaux J, Legouffe E, Jourdan E, et al. BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone. Blood. 2004;103:3148-3157.
39. Zhou HJ, Pham LV, Tamayo AT, et al. Nuclear CD40 interacts with c-Rel and enhances proliferation in aggressive B cell lymphoma. Blood. 2007;110:2121-2127.
40. Liu Y, Dong W, Chen L, Zhang P, Qi Y. Characterization of Bcl10 as a potential transcriptional activator that interacts with general transcription factor TFllB. Biochem Biophys Res Commun. 2004;320:1-6.
41. Kuo SH, Chen LT, Wu MS, et al. Long-term follow-up of gastrectomized patients with MALT lymphoma: need for a revisit of surgical treatment. Ann Surg. 2008;247:265-269.
42. Mackay F, Schneider P, Rennert P, et al. BAFF AND APRIL: a tutorial on B cell survival. Annu Rev Immunol. 2002;21:231-264.
43. Farinha P, Gascoyne RD. Helicobacter pylori and MALT lymphoma. Gastroenterology. 2005;128: 1579-1605.
44. Gaide O, Martinon F, Micheau O, Bonnet D, Thome M, Tschopp J. Carma1, a CARD-containing binding partner of Bcl10, induces Bcl10 phosphorylation and NF-kappaB activation. FEBS Lett. 2001;496:121-127.
45. Thornburg NJ. Pathmanathan R, Raab-Traub N. Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma. Cancer Res. 2003;63:8293-8301.
46. Brasier AR, Lu M, Hai T, Lu Y, Boldogh I. N F-κB-inducible Bcl-3 expression is an autoregulatory loop controlling nuclear p50/NF-κB1 residence. J Biol Chem. 2001;276:32080-32093.